BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1448 related articles for article (PubMed ID: 22275759)

  • 21. Regulation effects of TZQ-F on adipocyte differentiation and insulin action.
    Nan Xia J; Qin Zhang D; Du J; Wen J
    J Ethnopharmacol; 2013 Nov; 150(2):692-9. PubMed ID: 24095827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-Arginine improves multiple physiological parameters in mice exposed to diet-induced metabolic disturbances.
    Clemmensen C; Madsen AN; Smajilovic S; Holst B; Bräuner-Osborne H
    Amino Acids; 2012 Sep; 43(3):1265-75. PubMed ID: 22200933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet.
    Hamza N; Berke B; Cheze C; Le Garrec R; Umar A; Agli AN; Lassalle R; Jové J; Gin H; Moore N
    J Ethnopharmacol; 2012 Jul; 142(2):516-22. PubMed ID: 22633967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of diet-induced obesity by a combination of tea-catechin intake and regular swimming.
    Murase T; Haramizu S; Shimotoyodome A; Tokimitsu I
    Int J Obes (Lond); 2006 Mar; 30(3):561-8. PubMed ID: 16247510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.
    Cho AS; Jeon SM; Kim MJ; Yeo J; Seo KI; Choi MS; Lee MK
    Food Chem Toxicol; 2010 Mar; 48(3):937-43. PubMed ID: 20064576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
    Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.
    Tulipano G; Vergoni AV; Soldi D; Muller EE; Cocchi D
    J Endocrinol; 2004 Nov; 183(2):289-98. PubMed ID: 15531717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21.
    Müller TD; Sullivan LM; Habegger K; Yi CX; Kabra D; Grant E; Ottaway N; Krishna R; Holland J; Hembree J; Perez-Tilve D; Pfluger PT; DeGuzman MJ; Siladi ME; Kraynov VS; Axelrod DW; DiMarchi R; Pinkstaff JK; Tschöp MH
    J Pept Sci; 2012 Jun; 18(6):383-93. PubMed ID: 22565812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
    Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
    Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
    Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
    Patel V; Joharapurkar A; Gandhi T; Patel K; Dhanesha N; Kshirsagar S; Dhote V; Detroja J; Bahekar R; Jain M
    J Diabetes; 2013 Jun; 5(2):163-71. PubMed ID: 22830490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
    Nakagawa T; Ogawa Y; Ebihara K; Yamanaka M; Tsuchida A; Taiji M; Noguchi H; Nakao K
    Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
    Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice.
    Binder E; Bermúdez-Silva FJ; Elie M; Leste-Lasserre T; Belluomo I; Clark S; Duchampt A; Mithieux G; Cota D
    Obesity (Silver Spring); 2014 Mar; 22(3):713-20. PubMed ID: 23894080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.